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Small human thymocytes (ST) representing 70% of the 
thymocytes were isolated according to size by centrifugal 
elutriation. Although these ST contained approximately 
30% PNA~ cells, they failed to respond to lectins, indicat­
ing the existence of a PNA~ ST subset that can be consid­
ered to belong to the “immature” thymocyte population. 
The ST were induced to proliferate if, in addition to PHA, 
IL 1-containing supernatants of highly purified monocyte 
cultures or 12-0-tetradecanoyl-phorbol-13-acetate (TPA) 
were present. The incubation of the ST for 90 hr with TPA 
or IL 1 in the absence of PHA resulted in a strong reduction 
in the percentage of cells reacting with the immature 
thymocyte markers TdT and PNA. In addition, the OKT6+ 
cells were partially reduced after incubation with IL 1. 
Concomitantly, an increase in the percentage of cells 
reacting with the mature T cell markers OKT1 and OKT3 
was observed, whereas HLA antigens became strongly 
expressed on all ST. Although IL1 or TPA were unable to 
induce proliferation of the ST, these substances induced 
IL 2 production by these cells. These shifts to cells with 
more “mature” phenotypes that are able to produce IL 2 
were not observed if the ST were incubated with PHA or 
culture medium only. The responder capacity of the ST to 
PHA plus TPA was not significantly affected by the deple­
tion of the more “mature” OKT3+ and OKT1+ cells. In 
addition, in this situation OKT1+, OKT3+, OKT6" cells were 
found to be generated from OKTT, OKT3", OKT6+ cells. 
Therefore, it could be excluded that the proliferative re­
sponses were due to a selective expansion of a pre­
existing mature T cell population. Our results indicate that 
TPA mimics IL 1 in the induction of differentiation of the 
ST to a stage in which subpopulations of these cells are 
able to produce IL 2 and to respond to PHA. Because only 
the proliferating ST were found to react with a monoclonal 
antibody, which is thought to be directed at the IL 2 
receptor (anti-Tac), our data suggest that PHA is required 
for the induction of expression of receptors for IL 2 in 
those ST subpopulations that are able to proliferate in the 
presence of IL 2 generated in situ.
Monocytes/macrophages have been shown to be required for 
optimal lectin-induced T cell proliferation in vitro (1-8). This 
monocyte/macrophage function could be replaced in a nonres­
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tricted way by interleukin 1- (IL 1)2 containing media of monocyte 
cultures (1, 9, 10) or by 12-0-tetradecanoyl-phorbol-13-acetate 
(TPA) (10-14). IL 1 and TPA were also found to be capable of 
inducing lectin responsiveness of small human thymocytes (ST), 
which represented 70% of all thymocytes (11,15). In addition to 
their lack of lectin responsiveness, these ST failed to respond to 
alloantigens and therefore were considered to represent an 
“immature" thymocyte subset. Because it has recently been 
proposed that interleukin 2 (IL 2) is the only mitogenic signal for 
T cells (16, 17), and IL 2 production is shown to require the 
presence of accessory cells, IL 1 produced by these cells (18- 
20), or TPA (12,14, 21, 22), it seems likely that the lack of lectin 
responsiveness of the ST has to be attributed to the failure of 
these cells to produce IL 2,
It is well established that TPA induces differentiation of a large 
variety of cells (23) including human T lymphocytes and thymo­
cytes (11,24,25). Taken together with the observation that IL 1 
can induce thymocyte differentiation (9, 11, 26), these data 
prompted us to investigate whether the induction of PHA re­
sponsiveness of the ST by IL 1 or TPA was the result of the 
generation of immunocompetent T ceils from the “immature” 
ST. This question is of interest because there is some contro­
versy regarding the contention that all immature cortical thymo­
cytes are able to mature to immunocompetent T cells in the 
presence of IL 2. Various investigators have shown that imma­
ture peanut agglutinin-positive (PNA+) murine thymocytes could 
differentiate to cytotoxic T cells in the presence of IL 2 (27-30). 
In contrast, other investigators have excluded IL 2-mediated 
maturation of PNA+ thymocytes to immunocompetent T cells 
both in murine (31, 32) and in human systems (33). The recent 
observations in mice made by Chen et ai (32) demonstrated that 
the frequency of cytolytic precursor cells and precursors of cells 
capable of proliferation in the PNA+ cell population Is low com­
pared to those in the PNA” subset and probably has to be 
attributed to contamination with PNA* cells,
In this paper, we show that both IL 1 and TPA induce pheno­
typic differentiation of "immature” human ST to a point at which 
subpopulations of these cells are able to produce IL 2 and to 
respond to PHA.
MATERIALS AND METHODS
Media and reagents. All cell cultures and tests were carried out in Dulbec- 
co’s modification of Eagle’s minimal essential medium (DMEM) supplemented 
with 3.8 g NaHC03/liter, L-glutamine (2 rnM), penicillin (100 lU/ml), strepto­
mycin (100 fungizone (2.5 ng/ml), and 10% heat-inactivated (45 min, 
56°C) fetal calf serum, all purchased from GIBCO Biocult (Glasgow, Scotland). 
This medium was designated as culture medium. Purified phytohemagglutinin 
(PHA) was purchased from Wellcome, Beckenham, England. TPA, batch 26,
2 Abbreviations used in this paper: IL 1, interleukin 1; IL 2, interleukin 2; TPA, 
12-0-tetradecanoy!-phorbol-13-acetate; ST, small thymocytes; PNA, peanut agglu­
tinin; TdT, terminal deoxynucleotldyl transferase; FITC, isothiocyanate.
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was obtained from Consolidated Midland Corp., Brewster, NY. TPA was 
dissolved in ethanol at a concentration of 10 mg/0.5 ml and stored at -8 0 ° C 
as a stock solution of 0.4 mg/ml diluted in DMEM without serum. TPA was 
diluted to the appropriate concentration in culture medium just before use. 
Affinity-purified goat antibody to terminal deoxynucleotidyl transferase (TdT)
(34) was a gift from Dr. F. J. Bollum, Uniformed Services, University of the 
Health Sciences, Bethesda, MD. Fluorescein isothiocyanate-(FITC) labeled 
PNA was purchased from L’Industrie Biologique Française, Clichy, France
(35). Tritiated thymidine (3H-TdR, specific activity 6.7 Ci/mmol) was obtained
from New England Nuclear, Boston, MA.
Monoclonal antibodies. Monoclonal antibodies directed against human T 
cell differentiation antigens were used. The reactivity of the monoclonal 
antibodies OKT6 (36) and NA 134 (37) is restricted to human thymocytes, 
whereas OKT1 (38) and OKT3 react with most of the mature T cells (39). 
OKT4 reacts generally with T cells of the inducer or helper type (40), but also 
with a subset of cytotoxic T cells (41), whereas OKT8 reacts with the T cell 
populations that include cells with suppressor and cytotoxic functions (36). 
W 6/32 reacts with the heavy chains of all HLA-A, -B and -C determinants 
(42). Anti-Tac, which reacts with IL 2-dependent activated T cells but not with 
resting and IL 2-independent T cells (43, 44) and Is thought to recognize the 
IL 2 receptor (45), was kindly provided by Dr. T. A. Waldmann (Metabolism 
Branch, NCI/NIH, Bethesda, MD). The binding of these antibodies to viable 
cells in suspension was detected with FITC-labeled goat anti-mouse Ig. 
Fluorescence staining was evaluated by means of a fluorescence microscope 
as described (46).
Separation of thymocytes. Normal human thymus was obtained from 
children from the ages of 8 mo to 6 yr undergoing corrective cardiac surgery 
(kindly provided by Dr. H. J. Schuurman, University Hospital, Utrecht, The 
Netherlands). The fresh thymic fragments were collected in culture medium 
and carefully minced. Single thymocyte suspensions were prepared by press­
ing through a 200-mesh stainless steel mesh. The thymocyte suspensions 
were separated according to the size by a modified centrifugal élutriation 
procedure described previously (15). Approximately 70%  of the thymocytes 
were elutriated at a constant flow rate of 18 ml/min and a speed of rotation 
of 3000 rpm. This fraction contained a homogeneous population of ST judged 
by electronic sizing and cytocentrifugal preparations stained with May-Grün- 
wald-Giemsa stain. Accessory cells detected by staining for nonspecific 
esterase were absent. The viability of the thymocyte fractions was over 95% 
in all instances, determined by trypan blue exclusion.
Thymocyte cultures, 3 x  105 thymocytes were seeded in microtiter plate 
wells (no. 3040; Falcon Plastics, Oxnard, CA) in a final volume of 0.2 ml. PH A 
and TPA were added at concentrations of 1 and 0.1 Mg/mi, respectively, 
which were shown to be optimal (10). IL 1 was added at concentrations that 
have been shown to have the strongest mitogen Ic effects on murine thymo­
cytes (12.5 to 25% v/v). The cultures were incubated for 4 days, pulsed for
3 h with 0.4 fi®  3H-TdR, and harvested and counted as described (6).
Preparation of crude IL 1. In the first series of experiments, IL 1-containing 
supernatants were obtained from monocytes activated with TPA. Human 
monocytes were isolated by centrifugal élutriation of buffy coat celts obtained 
from 1 unit (500 ml) of blood (Central Laboratory of the Netherlands Red 
Cross Blood Transfusion Service, Amsterdam) as described (47). These 
purified monocyte fractions contained 95%  monocytes. Then 2 x  106 mono­
cytes were cultured in Linbro plates (No» 76-033-05; Linbro Chemical Co., 
New Haven, CT) in the presence of 0,1 ^g/ml TPA and 2.1 O'5 M indomethacin 
in a final volume of 2 ml. The 24-hr supernatants of these activated monocytes 
were collected, centrifuged at 1500 x  G for 10 min, and were used as crude 
IL 1 source. TPA was removed sufficiently from these culture supernatants 
by Millipore filtration (10, 48); culture medium in which TPA (0.1 ¿¿g/ml) had 
been incubated for 24 hr in the absence of monocytes failed to induce a 
proliferative response of the ST to PH A.
Most experiments, however, were carried out with IL 1 obtained from 
monocytes cultured on microcarrier beads (49) in serum-free medium (41) in 
the absence of TPA. The Cytodex microcarrier beads (Pharmacia Fine Chem­
icals, Uppsala, Sweden) were swollen in phosphate-buffered saline (PBS) for 
24 hr, washed five times with PBS, and autoclaved. After autoclaving, the 
beads were washed three times with PBS and resuspended in serum-free 
medium at a concentration of 100 mg/ml. The wells of the Linbro plates were . 
filled with 250 /¿I microcarrier bead suspension and subsequently with 4 x  
106 monocytes in the presence of 2 x  10 '5 M indomethacin. The final volume 
of the wells was 2 ml. After 24-hr incubation at 37 °C and 5% C 02, the culture 
supernatants were collected by centrifugation at 1500 x  G for 10 min and 
used as IL 1 source. Both crude IL 1-containing preparations were directly 
mltogenic for mouse thymocytes and enhanced the PHA-induced proliferation 
of murine and human thymocytes. Optimal effects were observed at concen­
trations of 12.5 to 25% (v/v). In addition, the IL 1 preparations did not contain 
interferon activity determined by neutralization of the cytopathic effect of 
vasicular stomatitis virus on murine L cells or IL 2 activity (measured as 
described below).
>tesay for IL 2 activity. The capacity of IL 2 produced by the thymocyte 
cultures to maintain T cell proliferation was tested as described by Gillis et 
al. (50) for murine IL 2'. The IL 2 activity was tested on a murine T cell line 
(TR) kindly provided by Dr. L. Aarden (Central Laboratory of the Netherlands 
Red Cross Blood Transfusion Service, Amsterdam, The Netherlands), which
was shown to be dependent on human IL 2 purified by high-pressure liquid 
chromatography and isoelectric focusing. TR cells (5 x  103) were cultured In 
200-fzl vol in flat-bottomed microplate wells in DMEM culture medium in the 
presence of a log2 dilution (ranging from 0.25 to 50% (v/v)) of a putative IL 2- 
containing thymocyte culture supernatant. After 24-hr incubation at 3 7 °C  and 
5%  C 02, the cultures were pulsed with 0.4 ¿¿Ci 3H-TdR, harvested 4  hr later, 
and counted as described (6). IL 2 activity was quantitated by probit analysis 
with the use of a 10% human IL 2 sample prepared from PHA-stimulated 
peripheral blood leukocytes of three different donors as standard, arbitrarily 
assigned a value of 100 U/ml. The PHA and/or TPA used for the stimulation 
of the thymocyte cultures did not interfere with the assay because the culture 
medium in which PHA and/or TPA had been incubated for 3 or 4 days had 
no proliferative effect on the TR cells. In addition, the TR cells did not respond 
to IL 1-containing supernatants of monocytes cultured in the presence of 
TPA or on microcarrier beads.
Depletion o f OKT-3+ thymocytes, 50 x  10® ST were collected in a  volume 
of 0.2 ml of PBS supplemented with 0.5%  bovine serum albumin (BSA) and 
incubated with 0.8 mi OKT3, 1/200 diluted in PBS for 60 min at 4 °C  with 
occasional shaking. After this incubation period, 0.2 ml of a selected batch of 
nontoxic 1/10 diluted rabbit serum was added as a C source, and the cell 
suspension was Incubated for another hour in a 3 7 °C waterbath with shaking. 
The cells were washed with PBS plus 0.5%  BSA and counted, The recoveries 
varied between 30 to 50% and the viability between 70 to 95%.
RESULTS
Differentiation state of ST incubated with TPA or IL 1 in the 
presence or absence of PHA. We previously showed that ST 
isolated by centrifugal eiutriation failed to respond to PHA, but 
that proliferation was induced if, in addition to PHA, irradiated 
allogeneic monocytes, crude IL 1 preparations, or TPA were 
added (11). Because mitogen responsiveness is a property of 
mature medullary thymocytes and both IL 1 and TPA can induce 
thymocyte maturation differentiation (9 ,11 , 26), we investigated 
whether the induced proliferation of the ST was a result of 
differentiation/maturation. The differentiation state of the ST 
before and after incubation with IL 1 or TPA in the presence or 
absence of PHA was determined by their reactivity with mono- 
clonal antibodies detecting T ceil differentiation antigens and 
HLA-A, -B, and -C antigens, and by their reactivity with PNA and 
TdT. The phenotype of the ST was not significantly different 
from that of the corresponding unfractionated thymocytes (Table 
I). In spite of their immature phenotype, 20 to 50%  of the cells 
in the ST population were found to react with the mature T cell 
markers OKT1 and OKT3. Interestingly, the ST also contained 
approximately 30% small PNA” thymocytes that, because of 
their lack of PHA responsiveness, can be considered to belong 
to the immature thymocyte population.
Incubation of the ST with TPA or IL 1 did not result in 
proliferation (Table II), but some degree of differentiation was 
observed, shown by the strong decrease in the percentage of 
cells reacting with PNAf TdT, and OKT4; these markers were 
still present on the ST incubated with culture medium or with 
PHA. In contrast to the ST incubated with IL 1, however, those 
incubated with TPA showed a considerable reduction in the 
OKT6+ and NA 134* cells. The percentage of OKT8+ cells was 
only slightly reduced. Furthermore, a strong increase in the 
percentage of cells expressing HLA antigens was observed, 
whereas the fluorescence intensity of these cells was also 
strongly increased (not shown). The percentages of OKT1 + and 
OKT3+ cells were significantly enhanced. The increase of the 
OKT3+ cells after incubation with TPA could only be observed 
after the cells had been washed and incubated overnight in 
culture medium, suggesting that the binding of OKT3 or expres­
sion of the OKT3 antigen was affected by TPA, Only the prolif­
erating ST were found to react with the anti-Tac antibody, 
suggesting that in addition to IL 1 or TPA, PHA is required for 
the expression of the receptors for IL 2. in these proliferating
cell populations, both blasts and non-blasts were Tac+ (not 
shown).
The simultaneous addition of IL 1 and PHA or TPA and PHA
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TABLE I
Phenotypic characterization of the unfractionated thymocytes and the corresponding ST before and after incubation with TPA or in the presence or absence of PH Aa
Unfractionated Thy' ST after 90 hr incubation with
/MIULKJUI69 mocytes O f TPA IL 1b PHA +  TPA PHA +  IL 1 PHA6 Medium
OKT1 29 ± 7 22 ± 3 50 ±  4 57 +  4 67 + 5 66 ± 4 18 + 5 19 ±  2
OKT3 36 ± 6 30 ± 4 53 +  3C 46 +  4 52 + 8C 58 ± 4 27 ± 5 34 +  3
OKT4 84 +  9 76 ± 7 14 + 4 12 ± 3 9 + 3 5 + 2 71 +11 65 ± 9
OKT6 87 ± 4 90 ± 5 90 ± 3 43 ± 4 13 + 1 6 +  2 78 + 6 83 ±  4
NA 134 82 ± 3 92 ± 3 94 ± 2 30 ± 5 8 ±  2 4 ±  1 NT NT
OKT8 86 ± 8 83 ± 5 70 ± 8 75 ± 6 72 ± 5 76 +  5 67 ± 1 0 80 ±  7
W6/32 37 ± 5 28 ± 5 96 ± 1 98 ± 1 92 ± 5 86 + 14 25 ± 6 35 ± 5
PNA 66 ±  8 71 ± 6 22 ± 5 15 +  5 32 ± 4 35 +  3 75 ± 8 6 1 + 5
TdT 85 ± 7 92 ± 4 0 0 NT NT 60 ± 1 5 7 1 + 8
Anti-Tacd NT 0 2 ± 1 1 +  1 32 ± 5 64 ±  5 4 ±  1 0
% Recovery® 26 + 4 30 +  3 73 + 9 60 ±  7 32 + 4 35 +  3
■ TPA was added at a concentration of 0.1 ^g/ml, PHA at 1 /¿g/ml, and IL 1 at a concentration of 12.5% (v/v). In two experiments, supernatant of monocytes activated 
with TPA (0.1 /ig/ml) was used as IL 1 source. This IL 1 preparation was mitogenic for BALB/c thymocytes (2.1 x 103 cpm) and enhanced the PHA response of these 
cells 20.6 times at concentrations of 25% (v/v). The other experiments were earned out with supernatant of monocytes cultured on microcarrier beads as IL 1 source. 
The latter induced a BALB/c thymocyte proliferation of 1.7 x 103 cpm and enhanced the PHA responses of these cells 44.1-fold. Percent positive cells (mean ±  SEM of 
four experiments). 
b Mean ±  SEM of three experiments.
° The percent of OKT3* cells after washing and resting overnight; direct determination: TPA: 13 ±  3, PHA +  TPA: 22 ±  8. 
d Mean ±  SEM of two experiments.
* The percent recovery compared with the number of viable cells seeded per well — 100%.
TABLE II
*H-TdR incorporation of the ST and corresponding unfractionated thymocytes after incubation with TPA or IL 1 in the presence or absence of PHAa
PHA TPA IL 1 PHA + TPA PHA + IL 1
Unfractionated thymocytes 
ST
19.0 ±  4.4fa 
0.4
4.3 + 0.6 
0.4
1.6 ±  0.5 
0.3
70.5 ±  20.1 
21.4 ±3.1
83.8 ± 1 7 .3  
18.0 ± 4 . 2
TABLE
Phenotyping and 2H-TdR Incorporation of ST and ST depleted of OKT3+ celts, 
before and after proiiferation induced with PHA (1 tig/ml) and TPA (0.1 ^g/mf)
* TPA was added at a concentration of 0.1 p.g/ml and PHA at 1 ^g/ml. Supernatant of monocytes cultured on microcarrler beads was used as IL 1 source at a 
concentration of 25% (v/v).
b 3H-TdR incorporation cpm x  103 (mean ±  SEM of three experiments).
resulted in proliferation of the ST (Table II). Characterization of 
the proliferating ST revealed a further shift to a more “mature" 
phenotype because in addition to a decrease in TdT+ and OKT4+ 
cells, a strong reduction in the percentages of OKT6+ and NA 
134+ cells was observed (Table I). The percentages of cells 
reacting with W 6/32, OKT1, and OKT3 were also considerably 
increased. Surprisingly, compared with the ST incubated with 
TPA or IL 1 only, these proliferating celis contained higher 
percentages of PNA+ cells. It should be noted that considerable 
cell death occurred during the incubation period; however, the 
recoveries of the surviving cells incubated with culture medium,
PHA, IL 1, or TPA did not differ significantly. Therefore these 
results suggest that IL 1 or TPA can induce some degree of 
phenotypic differentiation of a proportion of the ST.
Induction of proliferation of OKT1+- and OKT3+-depleted ST.
To exclude the possibility that proliferation induced by IL 1 and 
PHA or TPA and PHA was due to selective outgrowth of the 
more “mature” OKT1* and OKT3+ thymocytes present in the 
ST, the ST were depleted of OKT3* cells by lysis in the presence 
of C (Table III). Depletion of OKT3+ cells resulted in a concomitant 
depletion of OKT1+ cells. These OKT1+- and OKT3+-depleted 
ST responded almost equally well to PHA in the presence of 
TPA as did the corresponding non-OKT3+-depleted cell popula­
tion in the presence or absence of C. Approximately 50% OKT1+ 
and OKT3+ cells were detected in the proliferating ST, initially 
depleted of cells expressing these mature T cell antigens. It 
seems unlikely that the loss of OKT3+ cells was due to antibody- 
mediated modulation of the OKT3 antigen, because the OKT1 
cells were concomitantly removed by the antibody and C treat­
ment. In addition, 50 to 70% of the ST were found to be removed
, OKT3-.
Fresh





St initially de- 
ST pleted of
OKT3+ cells
% OKT3+ 34 ±  4 <3 
%OKT1+ 23 +  3 <3 
% OKT6+ 88 ±  4 91 ±  4
51 ±  5* 47 ±  3* 
60 ±  4 54 ±  4 
9 ±  3 15 ±  2
3H-TdR incorporation cpm x 103 22.4 ± 3 .2  17.8 ± 5 .0
a 3H-TdR incorporation (cpm x 103) of ST and ST initially depleted of OKT3* cells 
in the presence of complement was 20.9 ± 2 .8  and 18.5 ±  4.2, respectively (mean 
+  SEM of two experiments).
* Measured after washing and resting overnight In culture medium at 37°C and 
5 %  C O j.
TABLE IV
IL 2 production of ST after 4 days incubationa
Supernatants of ST Incubated with IL 2 Activity (U/ml)
PHA (1 ^g/ml)
TPA (0.1 /¿g/ml)
IL 1 (12.5% v/v)
PHA (1 Mg/ml) +  IL 1 (12.5% v/v)
ph a  (1 Mg/mi) + tp a  (0.1 Mg/ml)
Reference IL 2
0
30 ±  3
28 ± 4  
13 +  2 
10 +  4 
100
by this treatment. These results indicate that OKT1~
OKT6+ thymocytes under the influence of PHA and TPA can be 
induced to proliferate and that the proliferating cells differentiate 
to a “more mature” OKT1+, OKT3+, OKT6~ phenotype.
a Forty-eight hour supernatant of PHA-stimulated PBL from three different donors 
was used as reference (mean ±  SEM of three experiments).
induced T cell proliferation requires both an induction signal 
provided by IL 1 and a mitogenic signal from IL 2 (14). In addition, 
because TPA was found to mimic the signal provided by IL 1 
(11), we measured the IL 2 production of the ST after incubation 
with IL 1 or TPA in the absence or presence of PHA.
Although TPA or IL 1 in the absence of PHA did not induce 
proliferation, significant activity levels of IL 2 were found to be 
produced by these cells (Table IV). IL 2 production was also 
observed if IL 1 or TPA were added in the presence of PHA. In
IL 2 production by ST. Recently it was shown that lectin- this latter situation, however, lower IL 2 activity was detected in
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the supernatants, which probably could be attributed to IL 2 
consumption by the proliferating cells (14). The possibility that 
the growth-promoting activity of ST supernatants was due to 
PHA or TPA could be excluded (see Materials and Methods). In 
addition, the IL 1 preparations used for the activation of the ST 
were not found to have any detectable IL 2 activity.
These results indicate that ST incubated with IL 1 or TPA, in 
contrast to those incubated with culture medium or with PHA, 
mature to a point at which a proportion of these cells can produce 
IL 2.
DISCUSSION
The present results confirm and extend our previous findings 
demonstrating that ST fail to respond to PHA. Because the ST 
contained approximately 30% small, PNA' cells, these data 
indicate the existence of a PNA" immature thymocyte subset. 
The ST could be induced to proliferate by the addition of IL 1- 
containing supernatants of highly purified monocytes or TPA 
(11). it is shown that the lack of PHA responsiveness has to be 
attributed to the failure of the ST to produce IL 2, which is 
proposed to be only a mitogenic signal for T cells (16,17). The 
finding that IL 2 production by the ST was induced by the addition 
of exogenous IL 1 indicates that the lack of IL 2 production by 
the ST probably has to be attributed to the absence of accessory 
cells in these cell preparations. These data are in line with those 
of other investigators who demonstrated that IL 2 production 
only occurred in the presence of accessory cells of IL 1 produced 
by these cells (18-20). Furthermore, TPA that can replace mac­
rophage/monocyte functions in lectin-induced T cell proliferation 
(10-14) and IL 2 production (12, 14, 21, 22) was also found to 
be capable of inducing IL 2 production by the ST. Both TPA (that 
is mitogenic for human T cells (11, 24, 25) and mature thymo­
cytes (11)) and IL 1, however, failed to induce proliferation of the 
ST in spite of their capacity to induce significant IL 2 production 
by these cells. Recently, Stadler et aL (14) reported that IL 2 
production became detectable as lymphocytes stimulated by 
exogenous stimulants entered the later phase of This would 
imply that IL 1 and TPA induce the ST to shift from the G0 into 
the late phase. Proliferation of the ST was only observed if IL 
1 or TPA was added in combination with PHA. In addition, in 
contrast to the ST incubated with PHA, IL 1, or TPA only, the 
proliferating ST were found to bind the anti-Tac monoclonal 
antibody, which is thought to react with the receptor for human 
IL 2. These results suggest that PHA was required for the 
induction of expression of IL 2 receptors in those subpopulations 
present in the ST that are able to proliferate in the presence of 
IL 2 generated in situ. The possibility that the proliferation- 
maintaining capacity of IL 2 produced by the ST was due to 
some unknown effect of human proteins on the mouse T cells 
used for IL 2 determination could be excluded, because similar 
growth-promoting effects were observed on IL 2-dependent 
human T cell cultures (results not shown). Recently Maizel et al. 
(9) showed that human thymocyte mitogenesis was strongly 
enhanced in the presence of partially purified IL 1. Our results 
indicate that the proliferative responses to PHA induced by IL 1 
or TPA are actually mediated by IL 2.
Although both IL 1 and TPA were unable to induce proliferation 
in the absence of PHA, it was shown that TPA mimicked IL 1 in 
the induction of differentiation of the ST. The immature thymo­
cyte markers PNA and TdT were strongly reduced after 90 hr 
incubation with TPA or IL 1. Surprisingly, an increase in the 
PNA+ cells was observed in the proliferating ST that were 
cultured with IL 1 or TPA in the presence of PHA. These data 
are, however, in line with the observations of Schrader et al. (51)
who showed that the majority of PNA" murine thymocytes or 
lymph node cells change to PNA+ cells upon activation, which 
indicates that activated T cells acquire PNA-binding capacity. 
Furthermore, both TPA and IL 1 induced a strong reduction of 
the OKT4+ cells that was even more pronounced in the ST 
cultures that were induced to proliferate in the presence of PHA. 
The percentage of OKT8+ cells was only slightly reduced, dem­
onstrating that both the proliferating and nonproliferating cells 
were predominantly restricted to the OKT8+ phenotype. Similar 
observations were made by other investigators. Hayward et al.
(52) showed that human thymocytes activated with PHA in the 
presence of IL 2 belonged to the T3+, T8+ subset. Delia et a/.
(53) reported that leukemic cell lines that were phenotypically 
identical to normal cortical thymocytes lost their reactivity with 
TdT, PNA, OKT4, and OKT6 upon Incubation with TPA, whereas 
the percentage of OKT8+ cells remained unaltered. In our exper­
iments, IL 1 induced a partial reduction of the cells reacting with 
the thymocyte markers OKT6 and NA 134, whereas TPA had 
no effect. The OKT6* and NA 134+ cells were strongly reduced, 
however, in the proliferating ST cultures. The TPA- or IL 1- 
induced phenotypic modifications also included an increase in 
the cells expressing HLA antigens and the mature T cell markers 
OKT1 and OKT3. Taken together, these changes in phenotype 
suggest that incubation of the ST with TPA or IL 1 induced some 
degree of maturation. In spite of the considerable cell death that 
occurred during the incubation period (25 to 35% of the ST 
survived), it could be excluded that the observed differentiation 
was due to a selective survival of cells with a more mature 
phenotype. First, shifts to a more mature phenotype were not 
observed if the ST were incubated in culture medium only or in 
the presence of PHA, whereas the recoveries of viable ST after 
90 hr incubation in culture medium or PHA were comparable to 
those incubated with IL 1 and TPA. Secondly, TPA and IL 1 
induced IL 2 production, whereas incubation of the ST with 
culture medium or PHA failed to do so. In addition, the possibility 
that the PHA responsiveness induced by IL 1 or TPA was due 
to the selective outgrowth of the more mature OKT3+ thymo­
cytes could be excluded, because no clear reduction in the 
degree of proliferation could be observed in ST populations 
depleted for OKT3+ cells, whereas in this situation OKT1+, 
O K T3\ OKT6“ cells were found to be generated from OKT1~, 
OKT3~, OKT6+ cells. These data are in contrast to those of 
Hayward et al. (52) who reported that the proliferative responses 
of human thymocytes induced by PHA in the presence of IL 2 
were greatly reduced after depletion of OKT3+ cells. These 
differences in results are difficult to explain, but may be due to 
the differences in culture conditions and the fact that TPA or our 
IL 1 source are more effective in inducing maturation than their 
exogenous IL 2 source.
Our results, which indicate that both IL 1 and TPA induce 
maturation of the ST to a point at which subpopulations of these 
cells are capable of producing IL 2 and to respond to PHA, are 
in line with our previous observations indicating that TPA induced 
malignant T cell populations to differentiate and to produce IL 2 
(46). Similar findings, which indicate that immunologically unre­
sponsive thymocytes can be induced to differentiate to function­
ally active mature T cells, were also obtained with murine thy­
mocytes. Various investigators reported that immature cortical 
thymocytes isolated according to their reactivity with PNA could 
differentiate to mature cytotoxic T cells in the presence of IL 2 
(27-30). Contrasting results, however, have been obtained by 
other investigators. Bódeker et al. (31) excluded IL 2-mediated 
maturation of PNA* murine thymocytes because these cells 
could not be induced to become responsive to concanavalin A.
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Piantelli et al. (33) came to the same conclusion after investigating 
the PHA responsiveness of PNA* human thymocytes. Recently 
Chen et al. (32), with the use of murine thymocytes, demon­
strated by limiting dilution assays that the frequency of cytolytic 
precursor cells and the precursors of cells capable of proliferative 
responses in the PNA+ cell population were low compared with 
those in the PNA~ subset. Similar results were reported by 
Ceredig et a/. (54) who found that all cytolytic and helper precur­
sor cells were present in the mature medullary thymocyte subset. 
These data suggest that PNA+ murine thymocytes differ in 
maturation stage from our ST populations (separated according 
to size) in spite of the fact that both populations are considered 
to be “immature” because of their lack of mitogen and alloanti- 
gen responsiveness. This difference in maturation stage may be 
reflected by the 25 to 40% of small PNA~ cells present in the ST 
population, but because these PNA~ thymocytes are functionally 
immature and are therefore different from PNA~ medullary thy­
mocytes, it seems fair to conclude that PNA binding is not an 
unambiguous marker for immature human thymocytes. This 
notion is supported by the data of Umiel et al. (55) who demon­
strated that the PNA+ human thymocyte subset was heteroge­
neous in its response to PHA and IL 2. Only P N A \ OKT1 + 
thymocytes responded well to PHA in the presence of IL 2, 
whereas PNA+, O K T T  thymocytes remained unresponsive to 
PHA and IL 2. In addition, it cannot be excluded that PNA binding 
(that is required for the separation) may affect the functional 
properties of PNA+ thymocytes. The functional properties of the 
PNA“ thymocyte subset present in the ST are currently under 
investigation.
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